scholarly journals LEFT VENTRICULAR STRAIN BY CARDIAC MRI IN END-STAGE RENAL DISEASE PATIENTS AFTER KIDNEY TRANSPLANTATION

2018 ◽  
Vol 34 (10) ◽  
pp. S61-S62
Author(s):  
I. Gong ◽  
B. Al-Amro ◽  
G. Prasad ◽  
P. Connelly ◽  
D. Deva ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Renal Disease ◽  
Cardiac Mri ◽  
End Stage Renal Disease ◽  
Left Ventricular ◽  
Left Ventricular Strain ◽  
Stage Renal Disease ◽  
End Stage

Left ventricular strain in pediatric patients with end-stage renal disease

2019 ◽  
Vol 32 (3) ◽  
pp. 861
Author(s):  
MarwaG S Feteih ◽  
FahimaM Hassan ◽  
AhmedA Khattab ◽  
MahmoudA Soliman ◽  
RaniaS El-Zayat
Keyword(s):  
Renal Disease ◽  
End Stage Renal Disease ◽  
Pediatric Patients ◽  
Left Ventricular ◽  
Left Ventricular Strain ◽  
Stage Renal Disease ◽  
End Stage

scholarly journals Coronary microvascular dysfunction is associated with degree of anaemia in end‐stage renal disease

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Ashwin Radhakrishnan ◽  
Luke C. Pickup ◽  
Anna M. Price ◽  
Jonathan P. Law ◽  
Kirsty C. McGee ◽  
...  
Keyword(s):  
Confidence Interval ◽  
Renal Disease ◽  
Kidney Transplant ◽  
End Stage Renal Disease ◽  
Microvascular Dysfunction ◽  
Left Ventricular ◽  
Coronary Microvascular Dysfunction ◽  
Transplant Candidates ◽  
Stage Renal Disease ◽  
End Stage

Abstract Background Coronary microvascular dysfunction (CMD) is common in end-stage renal disease (ESRD) and is an adverse prognostic marker. Coronary flow velocity reserve (CFVR) is a measure of coronary microvascular function and can be assessed using Doppler echocardiography. Reduced CFVR in ESRD has been attributed to factors such as diabetes, hypertension and left ventricular hypertrophy. The contributory role of other mediators important in the development of cardiovascular disease in ESRD has not been studied. The aim of this study was to examine the prevalence of CMD in a cohort of kidney transplant candidates and to look for associations of CMD with markers of anaemia, bone mineral metabolism and chronic inflammation. Methods Twenty-two kidney transplant candidates with ESRD were studied with myocardial contrast echocardiography, Doppler CFVR assessment and serum multiplex immunoassay analysis. Individuals with diabetes, uncontrolled hypertension or ischaemic heart disease were excluded. Results 7/22 subjects had CMD (defined as CFVR < 2). Demographic, laboratory and echocardiographic parameters and serum biomarkers were similar between subjects with and without CMD. Subjects with CMD had significantly lower haemoglobin than subjects without CMD (102 g/L ± 12 vs. 117 g/L ± 11, p = 0.008). There was a positive correlation between haemoglobin and CFVR (r = 0.7, p = 0.001). Similar results were seen for haematocrit. In regression analyses, haemoglobin was an independent predictor of CFVR (β = 0.041 95% confidence interval 0.012–0.071, p = 0.009) and of CFVR < 2 (odds ratio 0.85 95% confidence interval 0.74–0.98, p = 0.022). Conclusions Among kidney transplant candidates with ESRD, there is a high prevalence of CMD, despite the absence of traditional risk factors. Anaemia may be a potential driver of microvascular dysfunction in this population and requires further investigation.

scholarly journals Significant Decrease in Plasma N-Acetyl-seryl-aspartyl-lysyl-proline Level in Patients with End Stage Renal Disease after Kidney Transplantation

2014 ◽  
Vol 37 (6) ◽  
pp. 1075-1079 ◽  
Author(s):  
Yosuke Suzuki ◽  
Fumihiko Katagiri ◽  
Fuminori Sato ◽  
Kanako Fujioka ◽  
Yukie Sato ◽  
...  
Keyword(s):  
Kidney Transplantation ◽  
Renal Disease ◽  
End Stage Renal Disease ◽  
Proline Level ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document